The non-pharmaceutical intervention will be guided by a certified movement facilitator working directly with hospital geriatricians, nurses, pharmacists, and therapists. Designed for individuals at various stages of the condition without requiring past experience, the auditory rhythm helps ease stiffness and promotes smoother walking. Alexandra Hospital aims to embed the practice into standard care regimens and potentially scale the initiative across Singapore's broader public hospital network.
Key points
Rhythmic auditory cues help patients' brains bypass damaged movement pathways to signific…: Rhythmic auditory cues help patients' brains bypass damaged movement pathways to significantly reduce freezing episodes.
The hospital intends to establish the dance movement program as a permanent component of…: The hospital intends to establish the dance movement program as a permanent component of standard clinical care.
Health officials plan to evaluate expanding the complementary movement therapy to other p…: Health officials plan to evaluate expanding the complementary movement therapy to other public healthcare institutions.
Sources checked by our analysis pipeline: 1
- Alexandra Hospital will prescribe dance from February 2027 for Parkinson’s patients. It aims to improve balance, movement, mood and reduce freezing.
- Research and international studies show rhythmic dance can help walking and coordination. AH says it is a targeted therapy, not a cure, and needs no dance experience.
- Parkinson’s cases at AH have tripled from 84 in 2022 to 256 in 2025. The hospital plans to make this standard care and may expand it to other public hospitals.
AI generated
SINGAPORE – From February 2027, patients at Alexandra Hospital (AH) diagnosed with Parkinson’s disease will be prescribed dance as part of their treatment.
Dance, one of the oldest human expressions that use rhythmic body movement to communicate, is helping to rewire how Parkinson’s patients are receiving care at the hospital.
Lim Huay Tin, who was diagnosed two years ago with the progressive, long-term neurological movement disorder, told The Straits Times she did not know how to dance.
But when the music started during a demo session for the media, the 80-year-old had no problems following the facilitator’s…
Federal regulators have provided detailed explanations regarding their decision to decline approval for Summit's pharmaceutical candidate. The move delivers critical regulatory clarity for the biotechnology sector as companies monitor agency review standards. Meanwhile, leadership at the regulatory body faces ongoing uncertainty following sudden executive staffing shifts.
Resistance from conservative lawmakers over controversial public health stances has derailed the administration's planned leadership pick for the nation's primary drug regulator. Meanwhile, clinical trial safety and efficacy concerns have forced a major pharmaceutical manufacturer to abandon an entire late-stage blood cancer program. These parallel setbacks disrupt both federal healthcare policy planning and corporate oncology pipelines.
Authorities in Greater Manchester are examining the circumstances surrounding a child who became critically ill during the afternoon at a Middleton childcare facility. Standard procedural inquiries are underway for fatalities occurring within care environments, with specialist officers deployed to assist the grieving family. Officials emphasize that the review remains preliminary as they gather information from the public.